Effects of <I>Yokukansankachimpihange</I> on Both Itching and Emotional Symptoms Affecting Atopic Dermatitis Patients

  • Kou Masahiro
    Dermatology of Sakai Hospital, Kinki University School of Medicine
  • Yudate Tatsuo
    Dermatology of Sakai Hospital, Kinki University School of Medicine

Bibliographic Information

Other Title
  • アトピー性皮膚炎患者の痒みおよび精神症状の改善に着目した抑肝散加陳皮半夏の効果

Search this article

Description

In this study, we evaluated the clinical usefulness of yokukansankachimpihange, which is expected to be effective for controlling chronic excitation symptoms, in AD patients. The subjects were 25 outpatients with AD. All subjects demonstrated a nervous predisposition and were obsessively self-concerned, frequently complaining of symptoms including easy fatigue, and all were readily excitable. As the test drug, yokukansankachimpihange (Kracie) was prescribed for 6 weeks in principle. Significant improvements were observed in the Kampo-based diagnosis of the symptoms as well as itching and irritation scores on VAS, and scores on Skindex 16 compared with before treatment. Based on the findings of this study, yokukansankachimpihange is considered to control itching or skin-specific symptoms that affect the quality of life in AD patients by suppressing emotional reactions that exacerbate the symptoms.

Journal

  • Hifu no kagaku

    Hifu no kagaku 8 (2), 244-248, 2009

    Meeting of Osaka Dermatological Association/Meeting of Keiji Dermatological Association

Details 詳細情報について

Report a problem

Back to top